VITALITY
Report
- Report Number
- 2124215-2010-17066
- Event Type
- Malfunction
- Date Received
- October 15, 2010
- Date of Event
- August 23, 2010
- Report Date
- October 11, 2010
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
THIS REPORT WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THIS DEVICE'S PROGRAMMED PARAMETER SETTINGS AND THERAPY HISTORY WERE USED TO ESTIMATE EXPECTED BATTERY USE TO DATE, THEN COMPARED TO ACTUAL USE. OUR INITIAL ANALYSIS SHOWED THIS DEVICE DID NOT MEET LONGEVITY EXPECTATIONS PER PROGRAMMED VALUES. ADDITIONAL ANALYSIS IS PENDING.
THIS DEVICE'S REPORTING STATUS IS CHANGED TO SERIOUS INJURY FROM MALFUNCTION DUE TO EXPLANT WITH EARLY ERI STATUS SUSPECTED. ANALYSIS OF THE RETURNED DEVICE IS PENDING.
UPON RETURN TO BOSTON SCIENTIFIC CRM'S (B)(4) LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THE DEVICE DECLARED ITS ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. ADDITIONAL LAB ANALYSIS AND TESTING SHOWED ERI WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILD-UP OF DEVICE INTERNAL BATTERY IMPEDANCE. THE EOL (END OF LIFE) INDICATOR WAS NOT DECLARED WHILE THE DEVICE WAS IN SERVICE. TESTING CONFIRMED ALL DEVICE THERAPIES WERE AVAILABLE.
THE DEVICE SUBSEQUENTLY WAS EXPLANTED AND REPLACED WITH NO REPORT OF ADVERSE PATIENT EFFECTS.
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS DEVICE DISPLAYED AN ELECTIVE REPLACEMENT INDICATOR (ERI) ASSOCIATED WITH A MIDDLE OF LIFE 2 BATTERY MEASUREMENT AND AN EXTENDED CHARGE TIME THAT EXCEEDED SPECIFICATIONS. THIS DEVICE IS INCLUDED IN THE MID-LIFE DISPLAY OF REPLACEMENT INDICATORS ADVISORY POPULATION COMMUNICATED 11/27/2007. IT ALSO WAS REPORTED THAT THE PATIENT WAS BELIEVED TO BE EXPERIENCING A PACED HEART RATE BELOW THE PROGRAMMED LOWER RATE LIMIT DUE TO PREMATURE VENTRICULAR CONTRACTIONS THAT COULD BE AFFECTING THE HEART RATE MEASUREMENT OR THE ATRIO-VENTRICULAR TIMING. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED, AND THE DEVICE REMAINS IMPLANTED AND IN SERVICE.
THE DEVICE SUBSEQUENTLY WAS EXPLANTED AND REPLACED WITH NO ADVERSE PATIENT EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | VITALITY | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | T127 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | (B)(4)| (B)(4)| (B)(4) |